CTIS2023-503355-98-00进行中（未招募）1 期
ION717-CS2
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study to test a medicine (fitusiran) for preventing bleeds in people with severe hemophilia who previously received preventive treatment with emicizumabMedDRA version: 20.0Level: LLTClassification code: 10060612Term: Hemophilia A Class: 10010331Hemophilia ACTIS2022-502414-84-00Sanofi-Aventis Research & Development26
进行中（未招募）
1 期
A trial to learn how baxdrostat affects the heartbeat in healthy participantsCTIS2023-506108-23-00Astrazeneca AB28
招募中
1 期
Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer’s disease.Parkinson's disease, Alzheimer's Disease, Multiple systems atrophy - parkinsonian variant, Dementia with Lewy BodiesCTIS2023-506508-18-00Z Leuven113
进行中（未招募）
1 期
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease ParticipantsAlzheimer’s DiseaseMedDRA version: 20.0Level: LLTClassification code: 10001896Term: Alzheimer's disease Class: 10029205CTIS2024-514004-14-00ovartis Pharma AG25
招募中
1 期
A Phase 1, open label, randomized, 2-sequence, 2-period, crossover, single center study to evaluate the pharmacokinetics of follitropin alfa from 2 manufacturing processes, administered as a single subcutaneous 450 IU dose to pituitary-suppressed healthy premenopausal female participants.InfertilityCTIS2023-507066-91-00Merck Healthcare KGaA14